BELGIUM – UCB has announced a strategic out-licensing of its AI-based fracture identification technology, BoneBot, to ImageBiopsy Lab, for further development and bring it to clinical practice by 2023. The…
Read MoreBELGIUM – UCB has announced a strategic out-licensing of its AI-based fracture identification technology, BoneBot, to ImageBiopsy Lab, for further development and bring it to clinical practice by 2023. The…
Read More